EPAM vs NICE
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
EPAM presents a classic value trap profile: fundamentally sound but technically broken. With a Piotroski F-Score of 4/9 (Stable) and a negligible Debt/Equity ratio of 0.04, the company is financially healthy, yet the stock is in a severe multi-year downtrend (-74.1% over 5 years). While the current price of $118.98 sits comfortably below the growth-based intrinsic value of $146.83 and offers an attractive PEG ratio of 0.71, the combination of bearish insider activity and a 0/100 technical trend suggests a lack of immediate catalysts for recovery.
NICE presents a classic deep-value opportunity, characterized by a stable Piotroski F-Score of 4/9 and a current price ($101.19) trading below its Graham Number ($117.16) and significantly below its intrinsic value ($280.55). The company maintains an exceptionally clean balance sheet with a Debt/Equity ratio of 0.02 and strong profitability margins. However, this fundamental strength is starkly contrasted by a severe technical collapse, with a 0/100 technical trend and a 57.4% decline over five years. The bullish thesis relies on mean reversion toward fair value, provided the recent earnings misses do not signal a permanent deterioration in growth.
Compare Another Pair
Related Comparisons
EPAM vs NICE: Head-to-Head Comparison
This page compares EPAM Systems, Inc. (EPAM) and NICE Ltd. (NICE) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.